Stephanie A. Haddad, Hematology/Oncology Fellow Physician and Wellness Chief Fellow at Mays Cancer Center at UT Health San Antonio, shared a post on X:
“Incredible presentation by Stephanie Graff at ASCO 2026 exploring one of the biggest questions in breast oncology today: first cytotoxic therapy – traditional chemotherapy or ADCs first?
Lots of thought-provoking data, clinical insights, and a glimpse into the future of treatment sequencing.”
Other articles about ASCO on OncoDaily.
